Aster Mankhool adds Gulf-first OCT heart imaging for 1 Dubai ACS patient

Aster Hospital Mankhool has become the first hospital in the Gulf to use the Cornaris P80/P80-E Optical Coherence Tomography (OCT) platform during a complex coronary intervention, according to a Gulf Business report published on 22 July 2026.

The highest-stakes readers are COOs, CFOs and medical directors. For Dubai operators, the immediate question is whether OCT becomes a differentiator in high-acuity catheter lab work, or a cost item that payers treat as an optional imaging add-on. Dubai Health Authority (DHA) regulates the Dubai facility through its licensed-facility framework. Comparable Abu Dhabi providers sit under the Department of Health Abu Dhabi (DOH), while providers in Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain are regulated by the Ministry of Health and Prevention (MOHAP).

What Aster has deployed

The platform named in the report is Vivolight Cornaris P80/P80-E, an OCT system used inside coronary arteries. Conventional angiography uses X-ray contrast images to show the vessel outline. OCT uses near-infrared light to produce cross-sectional views of the artery wall during the procedure.

Gulf Business said the first reported patient was a 52-year-old Dubai resident with type 2 diabetes, hypertension and high cholesterol who presented with worsening chest pain and was diagnosed with acute coronary syndrome, NSTEMI. That patient profile matters in the UAE because diabetes and lipid disorders raise the clinical value of precise lesion assessment during percutaneous coronary intervention.

“This technology allows us to see the heart artery in a completely new way.” Dr Naveed Ahmed, head of Cardiac Services, Aster Hospitals & Clinics UAE.

For medical directors, the clinical use case is narrow but material. OCT may help the interventional cardiologist assess plaque features, calcium burden, stent sizing and post-stent expansion. It does not replace the need for an interventional cardiology team, a licensed catheterisation laboratory, emergency response coverage and post-procedure monitoring.

Why clinics and insurers should care

For COOs, the commercial effect will depend on referral discipline. Clinics that see chest pain, abnormal stress tests or high-risk diabetic patients should confirm where they refer cases needing invasive assessment. The practical workflow is simple: document symptoms, risk factors, ECG findings, troponin results when available, and prior imaging before referral. In Dubai, that pathway should match DHA-licensed cardiology and emergency-care requirements.

For CFOs, the issue is authorisation. Public UAE prices for OCT as a separate line item are not consistently published. Market-facing UAE treatment portals list cardiac catheterisation at about $6,000-$9,000, or roughly AED 22,000-AED 33,000 at the UAE dollar peg, and balloon angioplasty at about $4,500-$10,000, or about AED 16,500-AED 36,700. One Dubai hospital package advertised for angioplasty is AED 43,000. These are self-pay benchmarks, not insurer tariffs.

• Ask the hospital for a written estimate that separates angiography, PCI, stent cost, OCT imaging and inpatient stay.
• Check whether the payer treats OCT as bundled, separately reimbursable or medically justified only for complex lesions.
• For Dubai plans, confirm pre-authorisation rules with the insurer and third-party administrator before elective PCI.
• For Abu Dhabi referrals, confirm DOH coding and network rules where Daman or Thiqa applies.

Sukoon and other private insurers may apply network, room-type and device-coverage limits. Patients should not infer coverage from the availability of the technology. Providers should give patients the payer approval number, expected co-pay and exclusions before admission when the case is elective.

What changes next

The competitive signal is that catheter lab technology is becoming part of Dubai hospital positioning. Aster Mankhool is listed in the DHA medical directory as Aster Hospital Br Of Aster DM Healthcare FZC at 9c Street 19, Dubai. The hospital also markets 24/7 emergency care and cardiology services, which gives it a direct route to ACS and complex coronary referrals.

Abu Dhabi and northern emirates operators should watch whether OCT enters more payer policies, package negotiations or specialist referral protocols in 2026. The near-term opportunity is strongest for hospitals with cath labs and emergency cardiac pathways. Clinics without cath labs can still benefit by tightening referral agreements and documenting eligibility for advanced coronary imaging.

Patients should ask two questions before choosing a provider: is the interventional cardiologist licensed for the procedure in that emirate, and is the hospital approved by the insurer for the planned intervention? For a licensed-provider check, start with the UAE Open Healthcare Directory, which lists cardiology providers, facility details and insurance information drawn from official licensed facility registers.